Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash & Current Investments: 2013-2017

Historic Cash & Current Investments for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2017 value amounting to $5.1 million.

  • Armata Pharmaceuticals' Cash & Current Investments rose 73.37% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $42.2 million, marking a year-over-year increase of 75.49%. This contributed to the annual value of $5.1 million for FY2017, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2017, Armata Pharmaceuticals' Cash & Current Investments is $5.1 million, which was down 0.00% from $5.1 million recorded in FY2016.
  • Armata Pharmaceuticals' 5-year Cash & Current Investments high stood at $20.4 million for FY2013, and its period low was $5.1 million during FY2016.
  • Moreover, its 3-year median value for Cash & Current Investments was $5.1 million (2017), whereas its average is $6.5 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' Cash & Current Investments crashed by 67.67% in 2014 and then spiked by 42.38% in 2015.
  • Armata Pharmaceuticals' Cash & Current Investments (Yearly) stood at $20.4 million in 2013, then plummeted by 67.67% to $6.6 million in 2014, then soared by 42.38% to $9.4 million in 2015, then crashed by 45.23% to $5.1 million in 2016, then remained steady at $5.1 million in 2017.